Management Strategies for Pediatric Patients with Thyroid Nodules

Overview

Pediatric thyroid nodules have a higher malignancy risk than adults, with differentiated thyroid carcinoma (DTC) showing >98% 30-year survival. Integrating sonographic, cytopathologic, and somatic oncogene analyses improves preoperative diagnostic accuracy and individualizes surgical management.

Background

Thyroid nodules in children often present as asymptomatic neck masses and carry a higher malignancy risk (19%-22%) compared to adults (12%-14%). Risk factors include family history, iodine imbalance, radiation exposure, and autoimmune thyroiditis. The incidence of pediatric thyroid carcinoma has increased since the 1990s, but survival remains excellent. Molecular profiling, especially somatic oncogene analysis, enhances risk stratification beyond traditional pathology.

Data Highlights

Key Findings

• Pediatric thyroid nodules have a higher malignancy risk than adults, necessitating careful evaluation.
• Somatic oncogene mutations, such as NRAS Q61, help predict malignancy and invasive behavior in thyroid nodules.
• Integrating ultrasound features, cytopathology (Bethesda system), and molecular testing improves preoperative diagnostic accuracy.
• Management aims to reduce treatment morbidity while maintaining excellent long-term survival.
• Diffuse thyroid enlargement with lymphadenopathy in children warrants ultrasound before lymph node biopsy.
• Prospective multicenter studies are needed to validate integrative diagnostic and management paradigms in pediatrics.

Clinical Implications

Clinicians should incorporate sonographic and cytopathologic findings with somatic oncogene analysis to better stratify malignancy risk and tailor surgical approaches in pediatric thyroid nodules. Early and accurate diagnosis can minimize unnecessary surgery and optimize outcomes. Awareness of higher malignancy rates in children compared to adults is critical for appropriate management.

Conclusion

An integrative approach combining imaging, cytology, and molecular genetics enhances the evaluation and management of pediatric thyroid nodules, supporting individualized care that balances treatment efficacy with reduced morbidity.

References

1. Cancer Genome Atlas Research Network 2014 -- Integrated Genomic Characterization of Papillary Thyroid Carcinoma
2. Pediatric Thyroid Carcinoma Epidemiology and Management Reviews 1990-2020